LEATCRT-G2 Trademark

Trademark Overview


On Tuesday, May 31, 2022, a trademark application was filed for LEATCRT-G2 with the United States Patent and Trademark Office. The USPTO has given the LEATCRT-G2 trademark a serial number of 97437065. The federal status of this trademark filing is REGISTERED as of Tuesday, July 4, 2023. This trademark is owned by Liling biopharmaceuticals (Suzhou) Co.,Ltd. The LEATCRT-G2 trademark is filed in the Pharmaceutical Products category with the following description:

Immunostimulants; Biological preparations for the treatment of cancer; Disinfecting wipes; First aid kits; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular...
leatcrt-g2

General Information


Serial Number97437065
Word MarkLEATCRT-G2
Filing DateTuesday, May 31, 2022
Status700 - REGISTERED
Status DateTuesday, July 4, 2023
Registration Number7100508
Registration DateTuesday, July 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesImmunostimulants; Biological preparations for the treatment of cancer; Disinfecting wipes; First aid kits; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 8, 2022
Primary Code005
First Use Anywhere DateFriday, May 13, 2022
First Use In Commerce DateFriday, May 13, 2022

Trademark Owner History


Party NameLiling biopharmaceuticals (Suzhou) Co.,Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJiangsu 215000
CN

Party NameLiling biopharmaceuticals (Suzhou) Co.,Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJiangsu 215000
CN

Party NameLiling biopharmaceuticals (Suzhou) Co.,Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJiangsu 215000
CN

Trademark Events


Event DateEvent Description
Tuesday, July 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 4, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 16, 2023ASSIGNED TO EXAMINER
Wednesday, June 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 3, 2022NEW APPLICATION ENTERED